PharmaBoardroom

Company Profile: Samsung BioLogics

It was less than a decade ago (2011) that Samsung BioLogics was a new kid on the block amongst Korea’s booming biotech conglomerates. Since then…

New Drugs Approved in Canada 2018

In total there were 27 new active substances (NASs) approved in Canada in 2018, 18 prescription pharmaceutical drugs and 9 biologics. In terms of…

Top 10 Drugs in Canada 2017

The Top 10 bestselling patented medicines in Canada for 2017. Janssen sold CND 938.1 million of its Remicade treatment for gastroenterology,…

The Ideal Pharma Country Manager: South Korea (Egon Zehnder)

Examining what it takes to be a country manager of a multinational pharma company in some of the world’s most challenging markets. Here, Eugene Kim,…

Sergio Rodriguez – CEO, Pfizer Spain

Sergio Rodriguez, CEO of Pfizer Spain, highlights the strength of the affiliate and the importance for the company in Europe, as well as the key areas…

Spain’s Clinical Trial Landscape

Within the past decade, Spain has developed into a top player in the European clinical trial network. The pharmaceutical industry has been increasing…

Rana Azfar – Vice-President & General Manager, Novo…

Rana Azfar, vice-president & general manager of Novo Nordisk Korea offers his impressions of the Korean market since moving from Pakistan. Azfar…

Juan Abarca Cidón – President, HM Hospitales, Spain

Dr Juan Abarca Cidón, president of HM Hospitales, one of Spain’s leading private health groups, gives insight into the private health sector of the…

Young-Woo Park – CEO, Y-Biologics, South Korea

Young-Woo Park, CEO of Y-Biologics - renowned for their library with diversity of 1011 - unveils their plan to be the first in Korea to develop the…

Damaso Molero – General Manager, 3P Biopharmaceuticals,…

Damaso Molero, general manager of 3P Biopharmaceuticals, a leading Spanish CDMO, highlights the growth of the company and the need to continuously…

Yong Zu Kim – Founder and CEO, Lego Chem, South Korea

Yong Zu Kim, founder and CEO of Lego Chem, discusses his company’s two areas of focus, anti-infectives and antibody drug conjugates. Dr Kim explains…

Antonio Alarco – Senator Elect of Tenerife; Former Health…

Dr Antonio Alarco gives his insider take on the future of Spanish healthcare, personalized medicine, and the areas in which Spain needs to improve.…

Tagged with A